Monopar Therapeutics
MNPR
#8837
Rank
S$0.11 B
Marketcap
$22.40
Share price
7.31%
Change (1 day)
789.85%
Change (1 year)

Monopar Therapeutics (MNPR) - P/B ratio

P/B ratio as of November 2024 : 14.6

According to Monopar Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Monopar Therapeutics - P/B ratio (from 2019 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-310.9051-70.18%
2022-12-313.0342.15%
2021-12-312.14-52.2%
2020-12-314.47-67.91%
2019-12-3113.9
2018-12-31N/A
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.39-83.64%๐Ÿ‡บ๐Ÿ‡ธ USA